Ronald Baden
Obstetrics & Gynecology · Friendswood, TXNPI 1912911702
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.2% of the total across 100 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by AbbVie at 37.9% of the total. Reporting peaked in 2021 at $591 and has fallen 79.5% since, to $121 in 2023.
Across 100 payments — averaging $17.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$682
- Pfizer$234
- Therapeuticsmd, Inc.$201
- Mayne Pharma Commercial LLC$170
- Avion Pharmaceuticals$87
- Lupin Inc.$86
- plus $339 from 12 others
What the payments were for
- Food & beverage$1,76598%
- Education$332%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 42 | $682 |
| Pfizer | 12 | $234 |
| Therapeuticsmd, Inc. | 8 | $201 |
| Mayne Pharma Commercial LLC | 6 | $170 |
| Avion Pharmaceuticals | 6 | $87 |
| Lupin Inc. | 5 | $86 |
| Currax Pharmaceuticals LLC | 5 | $81 |
| Aspira Women's Health Inc | 2 | $35 |
| Exeltis, USA Inc. | 2 | $33 |
| Nalpropion Pharmaceuticals LLC | 2 | $31 |
| Coopersurgical, Inc. | 2 | $29 |
| Acessa Health Inc. | 2 | $27 |
| Vertical Pharmaceuticals, LLC | 1 | $25 |
| Astellas Pharma US Inc | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Novo Nordisk | 1 | $16 |
| AMAG Pharmaceuticals, Inc. | 1 | $15 |
| Millicent US Inc | 1 | $15 |
How this compares
$1,798 in reported general payments places this provider in the 65th percentile of 3,099 obstetrics & gynecology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 16 | $735 |
| Gabapentin | 11 | $94 |
| Alendronate Sodium | 13 | $35 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Friendswood
- Devin GarzaAustin$2M
- Shawn TassoneAustin$1.3M
- Dale StovallDallas$590K
- Karyn-Anne CumberbatchMissouri City$452K
- Robert AsgharianEl Paso$366K
- Catherine HansenWebster$357K
- Lisa JukesBee Cave$270K
- Susan CrockettLive Oak$269K
- Henry Garza IiiSan Antonio$258K
- Rene LunaMcAllen$257K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.